Topical Scleroderma Medicine Seen to Lessen Fibrosis and Inflammation in Mouse Model

Topical Scleroderma Medicine Seen to Lessen Fibrosis and Inflammation in Mouse Model

A new topical medicine, called SM04755, significantly decreased and even reversed fibrosis and inflammation in in vitro and in vivo mouse studies of scleroderma. These results suggest SM04755 is a potential topical medicine for scleroderma patients.

The study, “Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Scleroderma” will be presented at the 2016 American College of Rheumatology (ACR) Annual Meeting taking place in Washington, D.C., on Nov. 11–16.

The Wnt signaling pathway constitutes a key regulator of many cellular processes, with important roles in inflammation, skin fibrosis, and blood vessels disease (vasculopathy), and, not surprisingly, it is hyper-activated in scleroderma.

Researchers performed a series of preclinical studies to investigate the effects of a novel small-molecule that is a Wnt pathway inhibitor, the SM04755, in several aspects of scleroderma: inflammation, dermal fibrosis, and vasculopathy.

To this end, they measured Wnt pathway inhibition by SM04755, and its anti-inflammatory activity, effect on fibrosis, and how it impacts myofibroblast differentiation (a key step contributing to fibrosis in scleroderma) and reversion. Researchers also measured the drug’s in vivo efficacy, testing it in a bleomycin-induced mouse model of scleroderma.

The team observed that SM04755 demonstrated potent and selective inhibition of Wnt signaling. Moreover, it showed anti-inflammatory activity (demonstrated by the reduced expression of key inflammatory markers) in two types of cell lines,  THP-1 and peripheral blood mononuclear cells (PBMCs). SM04755 treatment significantly inhibited dermal fibrosis, and was even capable of reversing the fibrotic phenotype.

SM04755 is a topical drug (meaning it is used locally, being applied on the area in need of treatment), and topical application to the scleroderma mice significantly reversed the induced dermal fibrosis. SM04755 treatment also lowered vasculopathy when compared to controls.

These effects were achieved with minimal toxic exposure. Altogether, the findings support SM04755 as a potential topical therapy for scleroderma.

SM04755 is being developed by Samumed, a pharmaceutical company working in tissue regeneration.

Yusuf Yazici, MD, chief medical officer of Samumed, said in a press release, “We are excited to return to the ACR Annual Meeting with seven presentations that highlight the progress we’ve made in five disease areas with two of our small-molecule compounds, SM04755 and SM04690.”

Those five areas are scleroderma, chronic tendinopathy, psoriasis, osteoarthritis, and degenerative disc disease.


  1. Kim Wright says:

    OMG this is good news for a Scleroderma suffer. Saying that I’m lucky that I’m not suffering any major effects – minimal. Minor skin fibrosis, mainly on lower arms a little on top arms. Skin still quite loose. Two digital ulcers, one on finger healed in 4 days, one in mouth just beginning to heal well after around 6 months. Lower lips slightly thinned, lost partial vision in left eye but has come back, itchy arms only, stiffening of upper arms and ankles but have totally gone. I’m on Cellcept, 250 mg moving up to 500 and thankfully very little lung effect but nowt to worry about. I think this is attributed to my suffering of eating extremely healthy and being hungry most days. I’m too scared to eat my usual way. I’ve cut out all bad wheat with gluten, cows milk. I try to eat organis where I can – mainly greens with nuts good oils, herbal teas and heavily researched supplements. This is the best news ever with the topical treatment which reduces the fibrosis. After reading much of he Scleroderma news which is very depressing, I now tend to be a little selective in my reading and tend to only read hopeful and positive news. If one reads doom and gloom news all the time and also has the disease, it just signals what future could likely hold and no one wants that thrusted in ones face all the time. I think if you keep a positive mind then it helps with surviving this kind of disease. Initially one has to get clued up with the disease to empower one to know how to help oneself. But after that there’s only so much the brain can process the onslaught of doom and gloom so I choose not to read it for the most part. This is exciting news and am so grateful to these medical scientist that research these almost cures. I just hope I get a second chance at life and so far life is offering me that. I’m healthy and look good and now back to looking younger than my age. I’m not giving life a bad chance and will continue with my extreme healthy eating.

Leave a Comment

Your email address will not be published. Required fields are marked *